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Among 268 patients undergoing percutaneous translu-
minal coronary angioplasty between February 1980and
January 1983, a total of 21 patients had variant angina,
documented before angioplasty in 14 and after angio-
plasty in 7. Before angioplasty, all 21 patients had rest
angina and 17 also had effort angina; single vesselcoro-
nary artery disease with 60 to 95% stenosis was present
in all patients and the left anterior descending coronary
artery was involved in all but 3 patients. Coronary an-
gioplasty was successful in 19 patients (90%). Eight of
the 19patients remained symptom-free without coronary
restenosis after successful angioplasty; in the other 11
patients, angina reappeared within 4 months, usually in
association with restenosis. Of the nine patients with
coronary restenosis, six had repeat angioplasty (fivesuc-
cessful procedures and one failure), two received medical
therapy and one underwent coronary bypass surgery.
Patients in whom calcium channel antagonists were dis-
continued immediately after angioplasty had an exceed-
In 1959, Prinzmetal et al. (I) described a clinical syndrome
characterized by angina at rest with concomitant transient
ST segment elevation on the electrocardiogram. They sug-
gested that "this variant form of angina pectoris resulted
from temporary occlusion of a large diseased artery due to
a normal increase in the tonus of the vascular wall." A few
years later, Gensini et al. (2) documented spontaneously
occurring coronary spasm associated with chest pain in a
patient with angina pectoris and mild coronary artery dis-
ease. The mechanism of coronary artery spasm is unknown.
Whether it represents a local abnormality of the arterial wall
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ingly high coronary restenosis rate (8 [80%] of 10 suc-
cessful attempts), but when calcium antagonists were
continued for an average of 6 ± 4 months after anglo-
plasty, the restenosis rate was low (3 [21%] of 14 suc-
cessful attempts).
After a mean (± SD) follow-up period of 33 ± 13
months, I patient had died and the 20 others (95%) were
symptom-free; among these 20, 15 patients (75%) had
been taking no antianginal drugs for more than 1 year,
2 still received calcium channel antagonists and 3 had
had coronary bypass surgery. Repeat coronary arteri-
ography performed 14 ± 7 months after angioplasty in
the 17 patients without angioplasty-related infarction or
surgery showed 50% or less coronary stenosis in 13 pa-
tients. Thus, coronary angioplasty appears to be an ef-
fective alternative therapy for patients with variant an-
gina and organic coronary stenosis.
(J Am Coil Cardiol 1985;5:1046-54)
or a normal or exaggerated vasomotion in response to var-
ious stimuli remains to be established (3).
The coronary anatomy of patients with variant angina is
quite variable , ranging from angiographically normal coro-
nary arteries (4) to severe multivessel disease (3,5-7) . How-
ever, the majority of patients with variant angina have some
degree of organic stenosis in the coronary artery susceptible
to spasm, and when present, the organic stenosis is the site
in that vessel where the spasm occurs in about 90% of cases
(8) .
The respective roles of spasm and fixed obstruction in
occluding a coronary artery may vary from patient to patient
(9) . According to MacAlpin (10) , significant coronary ob-
struction , even complete occlusion, can be dynamically
produced by physiologic degrees of vasoconstriction when
superimposed on even "insignificant" atheromatous ste-
nosis. Although an inappropriate active constriction appears
more likely than a physiologic one (II), for the same stim-
ulus resulting in a similar muscle contraction, the higher
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the degree of coronary stenosis, the higher the degree of
luminal reduction and impairment of flow. Under these con-
ditions, eliminating the organic stenosis would theoretically
prevent vasoconstrictive occlusion of the artery and would
relieve symptoms in patients with variant angina. Therefore,
we considered percutaneous transluminal coronary angio-
plasty as an alternative treatment for patients with variant
angina and significant coronary artery stenosis. In this re-
port, we describe immediate and long-term results of coro-
nary angioplasty and discuss the implications of our findings.
Methods
Patients. Between February 1980 and January 1983, a
total of 268 patients underwent coronary angioplasty at the
Montreal Heart Institute. Twenty-one of these patients were
considered to have variant angina. This was defined as spon-
taneous angina at rest with transient ST segment elevation
of at least 0.2 mY, relieved by nitroglycerin in less than 5
minutes and without subsequent evidence of myocardial
necrosis. It was also diagnosed when these events were
provoked by ergonovine administration.
The 21 patients were aged 36 to 69 years (mean ± SO
49 ± 10), all but 4 were men, all had rest angina for less
than 8 months (mean ± SO 2 ± 2) and all but 4 had effort
angina for I to 48 months (mean ± SO 6 ± II).
In most of the 21 patients, the diagnosis of variant angina
was made after referral and during hospitalization before
coronary angioplasty. In 7 of the 21 , the diagnosis was made
only after angioplasty from the demonstration of sponta-
neous or provoked episodes of variant angina within 4 months
after the procedure.
Patient management. Efforts were made to record a 12
lead electrocardiogram during spontaneous episodes of an-
gina at rest. Candidates for coronary angioplasty underwent
a graded treadmill exercise test with monitoring of IS
electrocardiographic leads with or without thallium-201
studies, with the exception of patients thought to have un-
stable angina. Patients were exercised during midmorning
using a Bruce protocol modified by adding a 3 minute warm-
up stage at 1.7 mph at a 5% grade (12,13). In patients with
suspected or documented variant angina, an ergonovine test
was performed in the coronary care unit (using a protocol
described in detail elsewhere [14]) if the patient had recently
undergone coronary arteriography, or occasionally during
coronary arteriography. Administration of ergonovine was
stopped if the test was still negative at a dose of 0.4 mg.
Before the angioplasty procedure, all patients were pre-
medicated with platelet function inhibitors (either sulfin-
pyrazone, 200 mg orally four times daily, or dipyridamole.
75 mg orally three times daily, plus aspirin, 650 mg orally
once daily) and diltiazem (90 or 120 mg orally three times
daily) on the day before and the morning of coronary
angioplasty.
Angioplasty technique. At the beginning of the pro-
cedure, low molecular dextran, 500 ml, was infused intra-
venously at a rate of ISO ml/h, a bolus of 10,000 IU of
heparin was administered intravenously and a nitroglycerin
infusion was started at a rate of 10 to 30 JLg/min. Intracor-
onary nitroglycerin was administered as required during the
procedure. Selective right and left coronary arteriography
was performed immediately before and after coronary an-
gioplasty by the percutaneous femoral approach using pre-
shaped polyethylene catheters (15). Coronary arteries were
filmed in multiple views, including craniocaudal and cau-
docranial sagittal-angulated views (16).
Coronary angioplasty was performed according to the
technique initially described by Gruentzig and Mayer and
their coworkers (17, 18). AU.S. Catheter and Instrument
Corporation inflation device was used for balloon inflation;
the inflation medium was contrast agent warmed and diluted
to 30% of the usual concentration. The number of balloon
inflations varied depending on the appearance of the lesion
as filmed during control angiography in at least three views
and on the residual gradient across the stenosis. Angioplasty
was termed successful if there was 20% or greater improve-
ment in the luminal diameter of at least one coronary ste-
nosis. Reduction of transstenotic pressure gradient was used
as a guide, but not as a sole criterion of success. For 24
hours after coronary angioplasty , all patients underwent con-
tinuous electrocardiographic monitoring.
Follow-up. All patients were asked to report to the hos-
pital for clinical evaluation and a graded treadmill exercise
test with 15 electrocardiographic leads at I, 3 and 6 months
after coronary angioplasty, including thallium-201 scans at
the I and 6 month exercise tests (13,19). In all patients,
coronary arteriography was performed 6 to 8 months after
angioplasty or sooner if restenosis was suspected (20). Sev-
eral patients had a second postangioplasty angiogram after
12 to 25 months. All patients received platelet function
inhibitors for 6 months after angioplasty (21). Medical treat-
ment of variant angina after angioplasty varied from patient
to patient and was influenced by the results of treatment in
earlier cases. Calcium channel antagonists were not admin-
istered after angioplasty in the first few patients or when
variant angina had not been diagnosed, but subsequent pa-
tients with known variant angina received them (usually
diltiazem, 120 mg three times daily). In most patients with
coronary restenosis, calcium channel antagonists were re-
started when angina recurred. Calcium channel antagonist
drugs were discontinued at least 24 hours before the ergo-
novine tests and whenever possible before the exercise tests.
All angiographic films were interpreted independently by
an experienced cardiovascular radiologist. Coronary artery
stenoses were defined according to the criteria of the Coro-
nary Artery Surgery Study (22). The estimated percent of
obstruction was derived from the angiographic view show-
ing the greatest reduction in diameter for the vessel in ques-
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Table 1. Clinical and Angiographic Data of 21 Patients Before Coronary Angioplasty
Duration of Electrocardiogram During Coronary Arteriogram
Diagnosis of
Age (yr) Angina (mo) Rest Ergonovine Exercise Variant Angina Vessel
Case &Sex Rest Effort Angina Test (rng) Test Before Angioplasty Involved Stenosis (%)
Patients With Primary Failure
I 66F 8 None t ST i ST (0.025) ST Yes Prox. LAD 80
2 48M I I i ST (0.05) Th pos. Yes Prox. LAD 90
Patients With Coronary Restenosis
3 42M 2 None i ST t ST (0.025) i ST Yes Prox. LAD 70
4 36M 2 2 J, ST No Prox. LAD 85
5 51M I I J, ST No Prox. LAD 60
6 69M I 48 J, ST No Prox. LAD 65
7 41M 3 3 Neg J, ST No Prox. LAD 60
8 59F I 7 No Prox. LAD 60
1st diag. 80
9 47M None i ST J, ST (0.025) ST Yes Mid LAD 80
Mid LAD 60
10 61M 3 13 i ST J, ST Yes Mid RCA 85
II 36M I I i ST Yes Mid CAD 85
Patients With Late Success
12 62F 4 4 i ST Neg" Yes Mid LAD 70
13 52M 4 4 Th pos. No Prox. LAD 90
14 SSM I 4 iST(O.i> i ST Yes Prox. LAD 95
15 42M I I i ST i ST (0.05) J, ST Yes Prox. LAD 90
16 48F I I i ST i ST (0.1) Neg" Yes Prox. LAD 90
17 38M I I t ST (0.1) i ST Yes Prox, LAD 85
18 38M I None i ST Yes Prox. LAD 80
19 47M 2 2 i ST Yes Prox. LAD 85
20 38M 5 5 i ST (0.1) Yes Mid RCA 70
21 60M I I No Prox. LCx 65
"Exercise test duration < 3 minutes. diag = diagonal artery; F = female; LAD = left anterior descending artery; LCx = left circumflex artery; M
= male; pos. = positive; prox. = proximal; RCA = right coronary artery; ST i and ST J, = ST segment elevation and depression, respectively; Th
= thallium scan.
Table 2. Summary of Clinical and Angiographic Data of 21
Patients Before Coronary Angioplasty
ginal attack occurred during hospitalization and the diag-
nosis was made after ergonovine administration. In the 10
tion. All measurements were made after the administration
of nitroglycerin, and all comparisons between pre- and post-
angioplasty films were made using the same view. Coronary
restenosis was defined as a 20% or greater decrease in lu-
minal diameter of the stenosis compared with the coronary
angiogram immediately after angioplasty, resulting in a
coronary stenosis of more than 50% at repeat angiography.
Results
Tables I to 6 summarize the clinical and angiographic
data before and after coronary angioplasty for the 21 patients
in this study. For clarity, the patients were classified into
three groups according to the results of angioplasty: primary
failure, restenosis or late success.
Findings before angioplasty (Tables 1 and 2). Variant
angina was documented before angioplasty in two-thirds (14
of 21) of the patients; in 9 of these 14, transient ST elevation
was present on an electrocardiogram recorded during spon-
taneous episodes of angina; in the other 5 patients, no an-
Age (yr)
Sex (no.)
Male
Female
Angina (no.)
Rest and effort
Rest only
Diagnosis of variant angina (no.)
Before angioplasty
After angioplasty
Single vessel disease (>50%)
Diseasedcoronary artery (no.)
Left anterior descending
Right
Left circumflex
Degree of stenosis (%)
49 :!: 10 (range 36 to 69)
17
4
17
4
14
7
20
18
2
I
77 :!: 12 (range 60 to 95)
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Table 3. Clinica l Follow-up of 2 1 Patient s After Co ronary Angiopl asty
Late Clinical Status
Early Clinical Status Calcium Clinical Status at Time of Restenosis Still
Electrocardiogram During Channel Electrocardiogram During Taking
Angina Antagonist Angina Time After Calcium
Rest Exercise Ergonovine After Rest Ergonovine Exercise Angioplasty Channel
Case Rest Effort Angina Test Test ( rng) Angioplasty Rest Effort Angina Test ( rngj Test (rno) Angina Antagonists
Patients With Primary Failure
Yes No 39 Not No
2 No Yes ST 24 Not :j: No
Patients With Coronary Restenosis
3 No No Neg Neg No No Yes t ST (0.2) i ST 40 No No
4 No No Neg No Yes* Yes i ST (0.2) i ST 37 No No
5 Yes Yes Neg t ST (0 .05 ) No No Yes i ST 36 NoH No
6 No No i ST No Yes No t ST i ST 6 -:j:§
7 No No No Yes' Ye~ i ST 35 No No
8 Yes Yes Neg No Yes Yes t ST 31 No No
9 No No Neg Yes Yes No t ST t ST (0 .05) Neg 29 No Yes
10 No No Yes Yes No t ST ((l.01) i ST 26 No No
II No No Neg No Yes No i ST 17 No Yes
Patients With Late Success
12 Yes No t ST Neg Yes 36 No No
13 No No Neg t ST (0.1) Yes 35 No No
14 No No Neg Neg Ye ~ 34 No No
15 No No Neg Neg Yes .n No No
16 No No Neg Yes 17 No No
17 No No Neg Yes 13 No No
18 No No Neg Yes 12 No No
19 No No Neg Yes 12 No No
20 No No Neg Yes 10 No No
21 Yes No Neg t ST (0.3) No 10 No:j: No
*In these two patients (Patients 4 and 7). ST segment elevation during spontaneous angina was documented only after the second coronary angioplasty.
t These three patients (Patients I. 2 and 5) underwent coronary artery bypass surgery during follow-up after angioplasty. :j:These four patients (Patients
2. 5. 6 and 21) had an acute myocardial infarction during follow-up after angioplasty. §This patient (Patient 6) died suddenly approximately I month
after an acute myocardial infarction. Abbreviations as in Table I.
Table 4. Summary of Clinical Follow-up of 2 1 Patient s
After An giop1asty
patients who underwent an ergonovine test (5 with suspected
and 5 with documented variant angina) , the test was negative
in I patient . induced ST depression in I and was positi ve
Duration (rno)
Status (no.)
Alive
Alive without myocardial infarction
or surgery
Alive after myocardial infarction
Uncomplicated surgery
Dead
Symptoms (angina) (no.)
Current medical treatment (no.)
None
Calcium channel antagonists
33 :t 13 (range 18 to 48)
20
16
.l
1
I
o
18
in 8 at a dose of 0.1 mg or less. Fourteen patients had an
exercise test that in six patients induced ST elevation in the
same electrocardiographic leads in which ST elevation oc-
curred durin g spontaneous or provoked anginal attacks , and
in four patients induced ST depression . In the rema ining
four patients the test produced no ST abnormality; in two
of the four, a reversible perfu sion defect was demonstrated
on the thallium exercise scan and in the other two , the
exercise test was stopped becau se of fatigue at 3 minutes
or less.
All patients had single vessel coronary disease with no
addi tional narrowings of greater than 50% in the other coro-
nary arteries. except for Pat ient 6, who had a 65% stenosis
of the posterior descending artery. The coronary stenosis
was graded between 60 and 95% and was located in the left
anterior descending artery in all but 3 patients (in the prox-
imal third in 15 patients) . ST elevation before or after coro -
nary angioplasty was located in the anterior electrocardio-
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Table 5. Angiographic Follow-up of 21 Patients after Coronary Angioplasty
% Stenosis Calcium % Stenosis Late Angiographic Findings
Immediately Antagonists at6 Months Time After
After First After or at Second Angioplasty Coronary Ergonovine Test;
Case Angioplasty Angioplasty Angioplasty (mo) Stenosis (%) Stenosis (%) (rng)
Patients With Primary Failure
I 80"
2 80 80~ HIOtt
Patients With Coronary Stenosis
3 20 No 70~ 25 25 25 ~ 70 (0.4) Clinically neg
4 30 No 80~ 30 21 100
5 40 No 75":1:
6 25 No 75~ 40:1:
7 30 No 70~ 40 21 40 Neg
8 50 No (60) 15 (55) Neg
60 80 70
9 30 Yes 70 22 70 ~ 95 (0.2)
35 (40) (40)
10 35 Yes 70~ 50 22 20 ~ 100(0.4)
II 50 No 70~ 35 7 70
Patients With Late Success
12 30 Yes 10 18 10 Neg
13 25 Yes 25 19 20 Diffuse narrowing (0.3)
14 50 Yes 40 19 30 Neg
15 60 Yes 50 18 50 Neg
16 10 Yes 35 6 35
17 10 Yes 10 6 10 Neg
18 10 Yes 20 6 20
19 35 Yes 30 12 30
20 30 Yes 20 8 20 ~ 85 (0.4)
21 25 No 25:1: 9 25 Neg
"Elective coronary artery bypass surgery; temergency coronary artery bypass surgery; :l:myocardial infarction. Neg = negative.
Table 6. Summary of Angiographic Follow-up of 17 Patients
After Angioplasty
graphic leads in all patients with left anterior descending
artery stenosis and in the inferior leads in the other three
patients. Left ventricularejection fraction was 0.50 or greater
in all patients.
Findings after coronary angioplasty (Tables 3 to 6).
Angioplasty was successful in all but two patients (Table 5).
Failures. In Patient I, the lesion could not be crossed,
variant angina continued despite optimal medical therapy
and she underwent coronary bypass surgery associated with
plexectomy 12 days later. Surgery was uneventful, but ep-
Duration (mo)
Status (no.)
No more stenosis (>50%)
Restenosis (>50%)
Ergonovine test (no.)
Negative
Positive
14 ± 7
13
4
8
4
isodes of variant angina occurred in the early postoperative
period.
In Patient 2, the results of angioplasty were poor and
there was an 80% residual stenosis. Effort angina persisted
despite medical therapy and a second angioplasty was at-
tempted I month later. It resulted in a coronary dissection
with complete coronary occlusion complicated by a myo-
cardial infarction that was not prevented by emergency coro-
nary bypass surgery associated with plexectomy.
Primary 5ucce55. Coronary angioplasty was successful
in 19 (90%) of the 21 patients (Fig. IA and B, Tables 5
and 6). The primary success rate in our first 268 patients
who underwent angioplasty during the same period was
68%. None of the first angioplasty attempts in the 21 patients
was complicated by coronary spasm during the procedure.
Soon after successful angioplasty in the 19 patients, all
but 4 patients were symptom-free (Table 3). Patient 5 had
recurrence of rest and effort angina I month after angio-
plasty. Coronary angiography showed a 35% residual ste-
nosis with a spontaneous superimposed spasm resulting in
a 95% narrowing suppressed by nitroglycerin and reinduced
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Figure 1. Patient 10. Right coronary
arteriograms, left anterior oblique view.
A. Before the first percutaneous trans-
luminal coronary angioplasty, the ar-
teriogram reveals an 85% mid-right
coronary artery stenosis. B, Immedi-
ately after angioplasty, thisstenosis is
reduced to 35%. C, Angina recurred
approximately 4 months after angio-
plasty; the right coronary artery ste-
nosis at the site of angioplasty isjudged
to be 70% (other angiographic views
showed a tighter stenosis). D, A sec-
ond coronary angioplasty was per-
formed, reducing the stenosis to 50%
(also better shown in otherviews). E,
Sixmonths later, theangiogram shows
a 35% stenosis at the site of angio-
plasty. F, Onthe angiogram 18 months
after thesecond coronary angioplasty,
the stenosis is only 20%.
by ergonovine administration; with calcium channel antag-
onists, the ergonovine test became negative, but angina
persisted. Patient 8 did not show improvement after angio-
plasty. Patient 12 had episodes of variant angina immedi-
ately and 3 days after angioplasty but became symptom-free
with calcium channel antagonists. Patient 21 had an inferior
myocardial infarction 2 weeks after angioplasty. Ergonovine
administration induced severe spasm of the right coronary
artery but did not modify the 25% residual stenosis at the
origin of the left circumflex artery; spontaneous right coro-
nary artery spasm evident on the angiogram immediately
before angioplasty had been overlooked. The ergonovine
test became negative in four of the five asymptomatic pa-
tients who underwent this test before hospital discharge.
Coronary restenoses. Angina persisted or recurred I to
4 months after coronary angioplasty in nine patients (Cases
3 to II, Table 3). Seven of these nine patients had an
exercise test that induced ST depression in all but one pa-
tient. Four patients also had an ergonovine test that induced
chest pain and ST segment shifts in all. These nine syrnp-
tomatic patients had coronary restenosis at repeat angiog-
raphy I to 4 months after angioplasty (Fig. IC). In two
patients (Cases 3 and 5) in whom restenosis was diagnosed
at 4 months, a first repeat angiogram was performed. re-
spectively, at 2 months and I month after angioplasty had
shown ergonovine-induced coronary spasm at the site of
angioplasty without coronary restenosis at that time.
Late success. Coronary angiography 6 months after an-
gioplasty showed no coronary restenosis in Patients 12 to
20, who were symptom-free while taking calcium channel
antagonists after coronary angioplasty, or in Patient 21, who
had a myocardial infarction while not taking calcium chan-
nel antagonists 2 weeks after angioplasty and who later
became symptom-free while taking these agents (Table 3).
Patient 15 had recurrent rest and effort angina 4 months
after angioplasty while on nifedipinc therapy; an exercise
test induced ST elevation at the II th minute, but repeat
angiography did not show coronary restenosis. This patient
became symptom-free when diltiazem was added to the
nifedipine regimen.
Restenosis, angina and calcium channel antago-
nists. With the exception of Patients 15 and 21, all patients
with persistent or recurrent angina after coronary angio-
plasty had restcnosis at control angiography I to 4 months
later and all asymptomatic patients had continued success
after angioplasty (Table 3).
In the II patients taking calcium channel antagonists
immediately after successful angioplasty, all but 3 (Cases
9. 10 and 15) no longer experienced variant angina and the
restenosis rate was 18% (2 of II patients). In the eight
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patients not taking calcium channel antagonists immediately
after successful angioplasty , the restenosis rate was 86%
(seven of eight patient s).
Management of restenosis . With the exception of Pa-
tients 4 and 7 in whom variant angina was not diagnosed
until after the second coronary angioplasty , patients with
restenosis were treated with calcium channel antagonists,
usually in addition to a second angioplasty attempt. Repeat
angioplasty was attempted in six patients; it was successful
in five (Fig . 10, E, F, Table 5), but failed in Patient 6 (who
underwent angioplasty on a coronary stenosis slightly distal
to the site of the initial angioplasty). In this patient, coronary
spasm developed during the procedure, completely occlud-
ing the left anterior descending artery at the site of the initial
angioplasty, and intracoronary nitroglycerin was required
for relief of spasm. Six hours later, the patient had an acute
anterior infarction that was compli cated by two episodes of
ventricular fibrillation and transient heart failure; this patient
died suddenly I month later . The autopsy revealed a hem-
orrhage under a plaque associated with a 95% stenosis of
the left anterior descending artery, an anteroseptal infarction
and a mural thrombus. Patient 5 developed a new 75% left
main coronary artery stenosis not present at angioplasty or
at repeat angiography I month after angioplasty and also
had a 75% restenosis of the left anterior descending artery ;
this patient underwent a double aortocoronary bypass graft
procedure the day after repeat angiography, but surgery was
complicated by an acute myocardial infarction . Two patients
(Cases 8 and 9) were treated with calcium channel antag -
onists alone .
Of the five patients who had a successful second coronary
angioplasty, three were taking calcium channel antagonists
and two of them had a late success . The remaining two
patient s did not receive calcium channel antagonists because
variant angina was not diagnosed before the second angio-
plasty . In Patient 4, rest angina recurred 6 weeks after the
second angioplasty and at repeat angiography a 60% stenosi s
with provoked superimposed coronary spasm was shown at
the site of angioplasty. The patient had become symptom-
free while taking calcium channel antagonists, but subse-
quent angiography revealed a complete occlusion at the site
of angioplasty. In Patient 7, rest angina recurred I week
after repeat angioplasty; calcium channel antagonist therapy
was started I month after angioplasty and the patient became
symptom-free without coronary restenosi s.
Restenosis and calcium channel antagonists (all angio-
plasty attempts). In the overall 24 successful coronary an-
gioplasty attempts (19 primary successes and 5 successful
repeat angioplasties), the restenosis rate was 21% (3 of 14)
when patients had received calcium channel antagonists soon
after angioplasty, and 80% (8 of 10) when calcium channel
antagonists were not administered soon after angioplasty
(Tables 3 and 5). This difference is statistically significant
(p < 0.014, Fisher's exact test) .
Late outcome. The mean (± SO) duration of clinical
follow-up was 33 ± 13 months (range 6 to 48) (Tables 3
and 4). One patient died , but all the others remained symp-
tom-free. Three had coronary bypass surgery and no longer
required antianginal therapy. Two were still taking calcium
channel antagonists . In each of the remaining 15 patients,
calcium channel antagonists have been discontinued for more
than 1 year (mean ± SO 25 ± 10 months), and these
patients remained symptom-free. Calcium channel antago-
nists were stopped 6 ± 4 months after coronary angioplasty
in patients with continued success and 12 ± 3 months after
repeat angioplasty in patients who had restenosis.
Repeat angiography was available at 14 ± 7 months
(range 6 to 25) in all 17 patients who had neither myocardial
infarction associated with angioplasty nor surgery (Tables
5 and 6). One had a complete coronary occlusion at the site
of angioplasty and three still had a significant coronary
stenosis of greater than 50%, with spontaneous superim-
posed spasm in one patient (Case II) . Twelve patients
underwent an ergonovine test which was usually performed
during the last repeat angiographic study. The test was neg-
ative in eight patients but induced a 70% spasm in Patient
3; it was positive in four patients at a relatively high dose
level of ergonovine (0.2 mg or more).
Discussion
Organic coronary stenosis in variant angina. Previous
reports (23 ,24) showed that in patients with variant angina
the extent and severity of organic coronary stenoses were
the strongest predictors of survival and survival without
myocardial infarction. Patients with variant angina should
undergo coronary angiography since the clinical or electro-
cardiographic manifestations do not distinguish patients with
angiographically normal coronary arteries from those with
severe proximal obstructive lesions . In fact, the therapeutic
choice may depend, to a great extent, on the presence or
absence of organic atherosclerotic lesions associated with
coronary spasm.
Coronary spasm associated with significant atheroscle-
rotic coronary lesions is relatively frequent; among 162
consecutive patients with variant angina undergoing coro-
nary arteriography at our institution, 59% had organic le-
sions of 70% or more (23) . Until recently, coronary bypass
surgery was the only available therapy for immediate re-
vascularization in these patients . However, coronary bypass
surgery is associated with a higher operative risk, a higher
postoperative myocardial infarction rate and poorer results
in these patients than in other subsets of patients with fixed
coronary obstructions (6,25-27) .
Coronary angioplasty in variant angina. Until re-
cently, coronary spasm was considered a contraindication
to coronary angioplasty. Indeed, since coronary spasm oc-
curred in 2% of patients undergoing angioplasty and was
lACC Vol. 5, No.5
May 1985:1046-54
CORCOS ET AL.
CORONARY ANGIOPLASTY FOR VARIANT ANGINA
1053
associated with myocardial infarction (17) or the need for
emergency coronary bypass surgery (28) in some patients,
angioplasty on an artery already affected by coronary spasm
seemed difficult and risky.
This study confirms our preliminary results (29) using
angioplasty for the treatment of variant angina and shows
that angioplasty is technically feasible in patients with this
condition. Moreover, the primary success rate in these pa-
tients was higher than that of the overall population of pa-
tients undergoing coronary angioplasty during the same pe-
riod, This probably occurred because most of our patients
fulfilled the ideal criterion for selection for angioplasty,
namely, discrete proximal noncalcified stenosis in a single
major coronary artery suitable for coronary artery surgery
(17), This pattern is more frequent in patients with variant
angina (29) than in the average group of patients undergoing
coronary arteriography (30). Coronary spasm occurred in
only two patients during 28 procedures (during repeat an-
gioplasty for both patients) and was complicated by myo-
cardial infarction in one. In the other patient with angio-
plasty-related myocardial infarction, this complication was
due to coronary dissection. Thus, the incidence of compli-
cations, particularly those related to coronary spasm, does
not appear to be much higher in these patients than that in
other patients who undergo coronary angioplasty (31) or in
patients with active variant angina (32).
Role of spasm in restenosis after coronary angio-
plasty. Coronary spasm demonstrated during the first 4
months after angioplasty may be a different problem. Var-
iant angina was diagnosed after angioplasty in 7 of our 181
patients successfully treated with angioplasty, and Hollman
et al. (33) recently described 5 patients representing 5 of
their 6 reported cases among 1,000 successful attempts.
Interestingly all of our seven patients and three of their five
patients had rest angina before angioplasty. Three of their
patients had a coronary stenosis of less than 60% before
angioplasty (one had an insignificant 37% coronary stenosis
2 weeks after a myocardial infarction). Only I of these 13
patients had an ergonovine test before angioplasty. Coronary
spasm did not develop immediately after angioplasty-in-
duced balloon injury, but after a symptom-free interval of
several days or weeks. In this setting, it appears difficult to
assume that coronary spasm diagnosed after angioplasty is
directly related to it. Variant angina occurring before an-
gioplasty, but discovered only after the procedure, appears
much more likely.
In two of our nine patients with coronary restenosis and
in four of the patients described by Hollman et al. (33),
coronary spasm in hemodynamically insignificant lesions
was demonstrated 2 to 7 months before the diagnosis of
restenosis. This finding, plus the fact that the rate of reste-
nosis is much higher in patients with variant angina than in
patients with a fixed coronary obstruction and seems to be
prevented by calcium channel antagonists, supports the hy-
pothesis that persistence of coronary spasm may playa role
in the pathogenesis of restenosis in patients with variant
angina. The possibility of variant angina should, thus, be
considered in patients with rest angina referred for coronary
angioplasty and in patients with restenosis after angioplasty
because they probably need specific medical management
after angioplasty similar to that of patients with variant
angina undergoing coronary bypass surgery (34).
Long-term clinical results. Our long-term clinical re-
sults must be interpreted with caution because spontaneous
remission is a frequent outcome of variant angina. However,
our proportion of patients currently symptom-free without
medical treatment for more than I year may be higher than
the rate reported in patients who had medical treatment alone
(35). Survival rate and survival rate without myocardial
infarction in our series are not different from those of pa-
tients with variant angina and single vessel disease who had
medical or surgical therapy (23,24). In patients with variant
angina and multi vessel disease who have been shown to
have the worst prognosis (23) and for whom coronary bypass
surgery has been advised, we have not yet had any expe-
rience of successful revascularization using coronary an-
gioplasty. We also have no experience of coronary angio-
plasty for mild to moderate « 50 to 60%) coronary stenoses
in vessels that exhibit coronary spasm; however, because of
the questionable role of these mild lesions, we doubt that
variant angina can be better controlled by coronary angio-
plasty plus calcium channel antagonists than by calcium
channel antagonists alone in most patients with these mild
fixed stenoses.
Role of calcium channel antagonists after angio-
plasty. In patients with variant angina and organic coronary
stenoses, coronary angioplasty is usually successful, but
restenoses, which may be induced by recurrent episodes of
coronary spasm. are frequent and seem to be prevented by
continuing administration of calcium channel antagonist drugs
for several months after angioplasty. Coronary angioplasty
can, thus, be proposed as an alternative therapy for these
patients. The subset of patients with variant angina and
organic coronary stenoses that should benefit the most from
this new method of revascularization remains to be determined.
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